Clincosm LogoSign in Get a demo

B-cell Lymphoma

Showing 26 - 50 of 95
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoid Leukemia, B-Cell Leukemia, Leukemia, Lymphocytic, B Cell Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Acute Lymphoid Leukemia
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor

Recruiting
  • B-Cell Lymphoma
  • +8 more
  • Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
  • Pittsburgh, Pennsylvania
    AHN Cancer Institute - West Penn Hospital
Aug 10, 2022

r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

Not yet recruiting
  • B-cell Lymphoma
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Aug 9, 2022

NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia Trial (KUR-502)

Not yet recruiting
  • NHL, Relapsed, Adult
  • +3 more
  • KUR-502
  • (no location specified)
Aug 2, 2022

Follicular Lymphoma, Marginal Zone Lymphoma, B-cell Lymphoma Trial in New Haven, New Brunswick, Providence (Mosunetuzumab,

Recruiting
  • Follicular Lymphoma
  • +2 more
  • New Haven, Connecticut
  • +2 more
Jul 14, 2022

B-cell Lymphoma, Burkitt Lymphoma Trial in Milwaukee (Etoposide, Doxorubicin, Cyclophosphamide)

Not yet recruiting
  • B-cell Lymphoma
  • Burkitt Lymphoma
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Jun 11, 2022

B-cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Hangzhou (QN-019a, Rituximab, Cyclophosphamid)

Recruiting
  • B-cell Lymphoma
  • B-cell Acute Lymphoblastic Leukemia
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical College of Zhejiang Uni
May 17, 2022

B-Cell Lymphoma Trial in United States (CPI-1205)

Completed
  • B-Cell Lymphoma
  • Lafayette, Indiana
  • +5 more
May 16, 2022

B-Cell Lymphoma, MDS (MDS), Acute Myeloid Leukemia (AML) Trial in Houston (Cyclophosphamide, CAR.70/IL15-transduced CB-NK cells,

Not yet recruiting
  • B-Cell Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 12, 2022

B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma Trial in Worldwide (CTX110)

Recruiting
  • B-cell Malignancy
  • +3 more
  • CTX110
  • Los Angeles, California
  • +27 more
May 6, 2022

Non Hodgkin Lymphoma, Follicular Lymphoma, Indolent Lymphoma Trial in Miami, Baltimore, Milwaukee (Zydelig)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • +8 more
  • Miami, Florida
  • +2 more
Apr 21, 2022

Detection and Characterization of Residual Masses in Lymphomas

Recruiting
  • Hodgkin Lymphoma
  • B-Cell Lymphoma
    • Créteil, France
      Hopital Henri Mondor
    Apr 20, 2022

    B-cell Lymphoma Trial in Sanhe (CD19/CD20 Dual-CAR-T cells)

    Completed
    • B-cell Lymphoma
    • CD19/CD20 Dual-CAR-T cells
    • Sanhe, Hebei, China
      Hebei Yanda Ludaopei Hospital
    Mar 6, 2022

    B-cell Lymphoma Trial in Beijing, Guangzhou (LP-168 tablet)

    Recruiting
    • B-cell Lymphoma
    • LP-168 tablet
    • Beijing, Beijing, China
    • +2 more
    Feb 24, 2022

    B-cell Lymphoma Trial in Belgium, France (selinexor, Rituximab, Dexamethasone)

    Completed
    • B-cell Lymphoma
    • Bruxelles, Belgium
    • +7 more
    Dec 6, 2021

    B-cell Lymphoma Trial in Randwick, Clayton, Fitzroy (Glofitamab, Gemcitabine, Oxaliplatin)

    Completed
    • B-cell Lymphoma
    • Randwick, New South Wales, Australia
    • +2 more
    Nov 23, 2021

    B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)

    Recruiting
    • B-cell Lymphoma
    • +8 more
    • Polatuzumab vedotin
    • Valhalla, New York
      New York Medical Center
    Oct 29, 2021

    B-cell Lymphoma Trial in China (Zanubrutinib)

    Completed
    Has Results
    • B-cell Lymphoma
    • Beijing, Beijing, China
    • +3 more
    Sep 26, 2021

    B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, ALL Trial in Boston (Venetoclax, Dexamethasone, Inotuzumab Ozogamicin)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Oct 19, 2021

    B-cell Leukemia, B-Cell Lymphoma Trial in Uppsala (CAR T cells)

    Completed
    • B-cell Leukemia
    • B-Cell Lymphoma
    • CAR T cells
    • Uppsala, Sweden
      Uppsala University Hospital, Dept of Oncology
    Oct 14, 2021

    B-cell Lymphoma Trial (Orelabrutinib tablet, Lenalidomide)

    Not yet recruiting
    • B-cell Lymphoma
    • (no location specified)
    Aug 23, 2021

    B-cell Lymphoma Trial in Kunming (CTA30X UCAR-T injection)

    Recruiting
    • B-cell Lymphoma
    • CTA30X UCAR-T injection
    • Kunming, Yunnan, China
      No.212 Daguan Road, Xishan District
    Aug 15, 2021

    Covid-19 Occurring in a Context of Non-Hodgkin Lymphoma

    Withdrawn
    • B-cell Lymphoma
    • Covid19
      • (no location specified)
      Aug 13, 2021

      B-Cell Leukemia, B-Cell Lymphoma Trial in Guangzhou (4SCAR19/22 T cells, Interleukin-2)

      Suspended
      • B-Cell Leukemia
      • B-Cell Lymphoma
      • Guangzhou, Guangdong, China
        Zhujiang Hospital of Southern Medical University
      Aug 9, 2021

      Cancer, Breast Cancer, Gastric Cancer Trial in Bron, Lyon, Pierre-Bénite (Blood draws)

      Recruiting
      • Cancer
      • +16 more
      • Blood draws
      • Bron, France
      • +16 more
      Jul 12, 2021